Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease
NCT ID: NCT01588067
Last Updated: 2015-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
271 participants
OBSERVATIONAL
2011-05-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
NCT01378260
Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion
NCT05586022
Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia
NCT02060630
Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)
NCT01419080
Analysis of the Different Strategies for Revascularization of the Lower Limbs by Peripheral Angioplasty
NCT05155462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The prospective cohort study will ask participants to complete health status surveys before they begin therapy for PAD and again 6 months later.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medical
Patients treated for PAD medically or with exercise therapy
No interventions assigned to this group
Endovascular
Patients with PAD treated with endovascular therapy
No interventions assigned to this group
Surgery
Patients with PAD treated with surgery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years of age,
* can complete a questionnaire, and
* has either had a change in PAD lower extremity intervention or start of a new intervention (surgical, endovascular, or medical therapy (cilostazol or exercise regimen)
Exclusion Criteria
* inability to consent,
* pregnancy,
* limited life expectancy (\< 6 months),
* previous endovascular or surgical revascularization within the previous 12 months,
* non English speaking
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Magid, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Kaiser Permanente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Eastern Colorado Health Care System
Denver, Colorado, United States
Kaiser Permanente Colorado
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CO-10-1488
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.